How does Angiotensin II Receptor Blocker (ARB) Therapy Compare to Angiotensin Converting Enzyme (ACE) Inhibitor Therapy in Prevention of Long-Term Complications in Idiopathic Hypertension?

Author

Makenzie Saxe, University of the PacificFollow

Date of Award

4-1-2019

Document Type

Capstone

Degree Name

Master of Physician Assistant Studies

Department

Physician Assistant Education

First Advisor

Rahnea Sunseri

Abstract

Medical evidence to date confirms that ACE inhibitors and ARBs provide equivalent blood pressure control. However, for prevention of specific outcomes, the data show stronger support for ACE inhibitors than ARBs, and vice-versa. Nonetheless, there is no clear answer as to whether one of these drugs has overall superiority for prevention of long-term complications of hypertension.

Recommended Citation

Saxe, Makenzie, "How does Angiotensin II Receptor Blocker (ARB) Therapy Compare to Angiotensin Converting Enzyme (ACE) Inhibitor Therapy in Prevention of Long-Term Complications in Idiopathic Hypertension?" (2019). Physician Assistant Capstones. 39.
https://scholarlycommons.pacific.edu/pa-capstones/39